Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Argininosuccinate synthetase 1 pseudogene 4 (ASS1P4) is classified as a pseudogene in the human genome[1]. Pseudogenes are genomic DNA sequences similar to functional genes but nonfunctional due to mutations or lack of regulatory elements. ASS1P4 shares sequence similarity with the *argininosuccinate synthetase 1* (ASS1) gene, which encodes an enzyme critical for the urea cycle and arginine biosynthesis. However, unlike ASS1, ASS1P4 does not produce a functional protein and has no established biological function, disease association, or role as a drug target. Its presence reflects evolutionary duplication events, and it serves no current therapeutic or biomarker purpose[1].\n\nIf you intended the functional enzyme *argininosuccinate synthetase 1* (ASS1), please specify, as that protein is clinically and pharmacologically relevant[2][3][4][5][6][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Argininosuccinate synthetase 1 pseudogene 4 (ASS1P4).